Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet signs multiple agreements with Papierfabrik Palm in Germany

Valmet Oyj press release, May 29, 2024, at 9:30 a.m. EESTValmet and Papierfabrik Palm GmbH & Co KG have signed a three-year Service Agreement and a one-year Performance Agreement to further improve the performance of Palm’s production lines Aalen PM5 and Wörth PM6. The agreements were included in Valmet's orders received of the first quarter 2024 and are effective immediately. The value of the agreements will not be disclosed. The agreements support Palm to become the benchmark for improvements in availability, profitability and safety at both mills. The agreements also ensure the

Viaplay Group to show UEFA club competitions in five Nordic countries

· Viaplay Group secures exclusive UEFA Champions League rights in Sweden and Denmark, exclusive UEFA Europa League and UEFA Conference League rights in Norway and Finland, and shared rights to all three competitions in Iceland until 2027 · Number of UEFA club competition matches, match days and kick-off slots to increase from 2024/2025 season · Viaplay Group remains world’s only broadcaster to have shown all matches from every UEFA Champions League season Viaplay Group has secured the exclusive rights to football from the men’s UEFA Champions League in Sweden and Denmark, exclusive

Monthly Update – April 2024

29 May 2024 Ashoka WhiteOak Emerging Markets Trust plc (the "Company") Monthly Update – April 2024 The Company's monthly factsheet as at 30 April 2024 is now available: https://awemtrust.com/factsheet/ The Company has delivered a NAV total return of 14.0% since inception to 30 April 2024, outperforming the benchmark MSCI EM1 (in sterling terms) by 429bps over the same period. Among other factors, stock selection within the small and mid-cap segment continues to drive outperformance. For the month of April 2024, the NAV was up 2.2%, outperforming the benchmark by 58bps.

Genetic Analysis AS: Publication of Q1 report January – March 2024

OSLO, NORWAY – May 29, 2024: Today, Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby publishes the interim report for the period January 1 – March 31, 2024. The interim report is available as an attached file to this release and on the Company's website. Below is a summary of the report.Ronny Hermansen, CEO of Genetic Analysis, comments:“During Q1 2024, GA has continued to onboard new laboratory customers by implementing the GA-map® assay on their instrument. A key objective for GA is technology implementation in laboratories since this generates recurring reagent

CapMan Growth appoints Timo Larjomaa as Senior Advisor

CapMan Growth press release29 May 2024 at 09:00 a.m. EEST CapMan Growth appoints Timo Larjomaa as Senior Advisor Timo Larjomaa has been appointed as Senior Advisor for the CapMan Growth team. Timo has long experience in international asset management from Intermediate Capital Group (ICG), where he worked for many years, most recently as Managing Director, Head of Nordics. Timo currently works as a private investor and is a co-investor in CapMan Growth's companies Silmäasema and Fennoa. "Timo brings us valuable know-how related to international business, larger-scale business

Nordec and Olvi sign agreement on delivery of new warehouse building in Iisalmi

Nordec Group Oy press release 29.5.2024 09.00 UTC+3 Nordec Oy and Olvi plc have signed an agreement on 14.3.2024 on the construction of the steel frame of a new warehouse building in Olvi plc's Iisalmi mill area. This is a significant project to build a new automated high-bay warehouse with an area of 3160 square metres and a height of 30 metresThe project, titled "Olvi plc, high bay warehouse, Iisalmi", is designed to meet Olvi plc's growing warehousing needs and streamline logistics processes. Iida-Maria Honkanen from Insinööritoimisto Savolainen Oy has been responsible for

SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing

STOCKHOLM, SWEDEN, - May 29, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of artificial intelligence (AI)-based solutions for skin disorders is pleased to announce the launch of the eBarrier Score for Nevisense, the first-ever AI skin barrier assessment tool built for use in research and cosmetic testing. The eBarrier Score was announced today at the Cosmetotest cosmetic testing symposium in Lyon, France.Researchers of the skin barrier and cosmetic products can now use Nevisense and the eBarrier Score to assess products and claims related to skin barrier function.

Sedana Medical completes patient recruitment for its clinical program in the US

Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 2 phase III clinical trial in the United States. Earlier this spring, Sedana Medical reported the completion of enrolment to the parallel phase III clinical trial INSPiRE-ICU 1. The company anticipates topline results from both trials in the second half of 2024, with a planned New Drug Application (NDA) submission in the first quarter of 2025.“The completion of INSPiRE-ICU 2 concludes Sedana Medical´s clinical trials in the United States. Running this study together with esteemed

Byggmax Group published updated financial targets

Byggmax Group AB (publ) today announce updated financial targets, affirming the commitment to driving future profitable growth and value creation. The Board of Directors has decided to update the financial targets to reflect the company’s ambition to grow beyond the market while delivering profitability and maintaining a strong balance sheet. Byggmax's efficient business model enables both dividends to shareholders and investment in growth."We have a clear roadmap to deliver on our targets. Based on our strong discount position, we will continue simplifying our operations, leveraging our

Sofia Ilmonen reveals a new SPINNOVA collection at Fashion in Helsinki

Hyères-awarded designer Sofia Ilmonen launches her third joint collection with Spinnova, showcasing modular outfits from fabrics made with SPINNOVA® fibre. The collection draws inspiration from the corset – one of the most controversial garments in the history of fashion – and is featured today at Fashion in Helsinki, an event showcasing the rising stars of the Finnish fashion industry. Taking place from May 28th to June 2nd 2024, Fashion in Helsinki showcases Finnish creativity, artistic practice and craftsmanship through fashion shows, presentations, and exhibitions. As this

Transaction in Own Shares

    28 May 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |28/05/2024|+---------------------------------------------------------------

Veidekke: Exercise of employee share options in Veidekke ASA

A total of 2 participants in the Company's share option program have on May 28[th] 2024 exercised a total of 1 500 options at a strike price of NOK 35.15. A total of 1 participant in the Company's share option program have on May 28[th] 2024 exercised a total of 2 000 options at a strike price of NOK 39.46. A total of 5 participants in the Company’s share option program have on May 28[th] 2024 exercised a total of 9 000 options at a strike price of NOK 99,36. Following the exercise, the employees will purchase 12 500 shares. These shares will be transferred June/July. Shares

TYRI Starts In-House Production of Circuit Boards in Sweden – The Factory Has a Capacity to Produce 3 Million Units Per Year

TYRI, a world leader in lighting for work machines, is starting in-house production of circuit boards in Sweden. The 1,800 square-meter factory in Kungsbacka will make the company self-sufficient in this area. By doing this, TYRI will achieve increased control, higher quality, and more reliable deliveries.“We see many advantages in producing the circuit boards we need ourselves. Increased quality and delivery reliability are two of the most important reasons. We will produce for our production facility in Gothenburg and also for our production units in the UK and the USA,” says Jimmy Nordén,

The Jätkäsaari Circular Economy Block will have a new circular economy brick as facade material

YIT Corporation Press Release 29 May 2024 at 9:00 a.m.The first circular economy block for lifelong learning in the Nordic countries will be built in Jätkäsaari, Helsinki. The circular economy block to be  implemented in Jätkäsaari is a communal apartment block that is designed, built and inhabited according to the circular economy concept. The developer of the project is the Yrjö ja Hanna Foundation, the turnkey project is carried out by YIT, the architectural design is carried out by ARK-House Arkkitehdit, and A-Insinöörit is responsible for the other design areas. The finished property

DBP International AB: European patent for the technology platform BeloGal® is granted

Double Bond Pharmaceutical International AB (publ) ("DBP" or the "Company", org. no. 556991-6082) has today, May 29, 2024, received information about the granting of a European patent application for organ-specific administration of hydrophilic cancer drugs to the liver. This applies, among other things, to one of the company's frontline products SA-033 for the treatment of liver cancer, which is based on the technology platform BeloGal®. The patent approval means protection for the product in 26 countries within the European Patent Office (EPO) at least until the year 2035. "The granted

Skanska builds data center in Georgia, USA, for USD 90M, about SEK 950M

Skanska has signed a contract with an existing client to build a data center in Georgia, USA. The contract is worth USD 90M, about SEK 950M, which will be included in the US order bookings for the second quarter of 2024.The project includes the construction of a 22,700 square-meter data center, associated site work, and underground utilities. The scope also includes a fit out of an administration space and five data halls. Work will begin in August 2024 and is scheduled for completion in February 2026.

Dolphin Drilling AS – First quarter 2024 financial results

(Oslo, 29 May 2024) Dolphin Drilling AS (Dolphin Drilling, OSE: DDRIL) today announced its unaudited results for the three months ended 31 March 2024. The highlights and subsequent events include: · Operating revenues of USD 10.1 million, EBITDA of USD (17.0) million, and earnings per share of USD (0.08) · Seamless integration of Paul B Loyd, Jr., on contract for Harbour Energy Ltd in the UK · New contract with Oil India for Blackford Dolphin · Reactivation and scheduled yard-stay underway for Borgland Dolphin. The rig’s next contract is with EnQuest Ltd in the UK · Sale

Limited liability companies and co-operatives that have not filed financial statements risk being struck off the Trade Register

The Finnish Patent and Registration Office (PRH), which maintains the Finnish Trade Register, will deregister or place into receivership limited liability companies and co-operatives that have not filed their financial statements for registration. The third deregistration in 2024 now includes circa 4.700 limited liability companies and co-operatives.The companies in the third deregistration must file their financial statements with the Trade Register by 11 September 2024. See the list of the companies in the deregistration (a reminder recorded on 27.5.2024): · Go to the prh.fi

BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development

Bergen, Norway, May 29, 2024 – BerGenBio ASA (OSE: BGBIO), a clinical-stage bio-pharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced financial results for the quarter ended March 31, 2024, and provided a business update.   Highlights, including post period: · Data Safety Monitoring Board review supported dose escalation in Ph 1b and initiation of Ph2a · Site activation of Ph2a in US and Europe proceeding well · Bemcentinib remains the leading selective AXL inhibitor in the clinic and was selected for

Circio announces financing that secures cash runway for twelve months

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.· Circio plans to raise up to approx. NOK 52 million in a rights issue at NOK 2.5 subscription price, with 1:1 warrant coverage · Certain existing and new shareholders have pre-subscribed for NOK 9.15 million, including NOK 1.77

Circio Holding ASA - Terms of the rights issue and related transactions

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Oslo, 29 May 2024: Reference is made to the stock exchange announcement made by Circio Holding ASA (the "Company") on 17  April 2024, regarding the Company's intention to carry out a rights issue (the "Rights Issue"). The board of

Prisma Properties intends to list its shares on Nasdaq Stockholm

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THE INFORMATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. PLEASE REFER TO "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE.Prisma Properties AB ("Prisma Properties", "Prisma" or the "Company"), a fast-growing property owner and property developer in modern necessity-driven discount retail, hereby announces its intention to list its

Finnish biology inventors selected as finalists for the European Inventor Award 2024

The husband-and-wife team, Sirpa and Markku Jalkanen, developed a clinical treatment to activate the immune system in fighting cancer cells. They were selected from over 550 candidates as finalists in the ‘SMEs’ category of the European Inventor Award 2024, competing against a French team and a Polish one. The winners will be announced during the ceremony on 9 July in Malta.Igniting the immune system to target cancer Bexmarilimab, the drug developed by this husband-and-wife team, better equips the immune system to fight cancer cells, making it a form of immunotherapy, which is an

There are no items matching the current filter
There are no more items matching the current filter
Back to top